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OBJECTIVE—An inﬂammatory process is involved in the mech-
anism of obesity-related insulin resistance. Recent studies indi-
cate that monocyte chemoattractant protein-1 (MCP-1) is a major
chemokine that promotes monocyte inﬁltration into adipose
tissues; however, the adhesion pathway in adipose tissues re-
mains unclear. We aimed to clarify the adhesion molecules that
mediate monocyte inﬁltration into adipose tissue.
RESEARCH DESIGN AND METHODS—We used a DNA
microarray to compare the gene expression proﬁles in epididy-
mal white adipose tissues (eWAT) between db/db mice and
C57/BL6 mice each fed a high-fat diet (HFD) or a low-fat diet
(LFD). We investigated the change of insulin resistance and
inﬂammation in eWAT in P-selectin glycoprotein ligand-1
(PSGL-1) homozygous knockout (PSGL-1
/) mice compared
with wild-type (WT) mice fed HFD.
RESULTS—DNA microarray analysis revealed that PSGL-1, a
major ligand for selectins, is upregulated in eWAT from both
db/db mice and WT mice fed HFD. Quantitative real-time RT-PCR
and immunohistochemistry showed that PSGL-1 is expressed on
both endothelial cells and macrophages in eWAT of obese mice.
PSGL-1
/ mice fed HFD showed a remarkable reduction of
macrophage accumulation and expression of proinﬂammatory
genes, including MCP-1 in eWAT. Moreover, adipocyte hypertro-
phy, insulin resistance, lipid metabolism, and hepatic fatty
change were improved in PSGL-1
/ mice compared with WT
mice fed HFD.
CONCLUSIONS—These results indicate that PSGL-1 is a cru-
cial adhesion molecule for the recruitment of monocytes into
adipose tissues in obese mice, making it a candidate for a novel
therapeutic target for the prevention of obesity-related insulin
resistance. Diabetes 60:189–199, 2011
O
besity is correlated closely with chronic low-
grade inﬂammation in adipose tissues and
insulin resistance, which causes systemic met-
abolic disorders (1). Accumulation of macro-
phages in adipose tissue is positively correlated with body
weight and insulin resistance in both humans and rodents
(2,3). Adipose tissue macrophages (ATMs) secrete a vari-
ety of proinﬂammatory cytokines and chemokines, includ-
ing tumor necrosis factor (TNF)- (4), interleukin (IL)-6,
and monocyte chemoattractant protein (MCP)-1 (5),
which enhance insulin resistance. ATM accumulation and
insulin resistance are ameliorated in MCP-1–deﬁcient
mice (6) and C-C chemokine receptor 2 (CCR2)-deﬁcient
mice (7) fed a high-fat diet (HFD). Conversely, overexpres-
sion of MCP-1 resulted in increased numbers of ATMs
along with the development of insulin resistance (6,8).
These ﬁndings indicate that ATMs enhance obesity-related
insulin resistance.
Monocyte inﬁltration into inﬂamed tissues is promoted
by chemokines and adhesion molecules that are expressed
on endothelial cells and monocytes (9). Selectin molecules
and those ligands mediate leukocytes rolling along the
activated endothelium, which is the ﬁrst step of leukocyte
recruitment into inﬂamed tissues. The second step is
monocyte adhesion on endothelial cells mediated by inter-
cellular adhesion molecule-1 (ICAM-1) or vascular cell
adhesion molecule-1 (VCAM-1). Earlier, we reported that
an inﬂammatory process is involved in the pathogenesis of
diabetic nephropathy and that ICAM-1 deﬁciency is pro-
tective against the development of renal injury in diabetic
mice without change of blood glucose (10–13). Several
studies in humans have shown that serum levels of soluble
ICAM-1 are elevated in obesity and positively correlate
with central adiposity (14,15) and insulin resistance (16).
Other studies have shown that serum levels of soluble
E-selectin are associated with BMI or insulin resistance
(17,18).
The predominant adhesion pathway of monocyte inﬁl-
tration into adipose tissue is unclear. To clarify the adhe-
sion molecules that promote monocyte inﬁltration into
obese adipose tissue, we screened the gene expression
proﬁles of adhesion molecules in adipose tissues from two
different types of obese model mice and evaluated the
functions of the candidate gene using gene knockout mice.
RESEARCH DESIGN AND METHODS
Animals and animal care. Six-week-old C57/BL6 (BL6) mice were purchased
from CLEA Japan (Tokyo, Japan). The db/db mice (C57BL/KsJ-db/db) and
P-selectin glycoprotein ligand-1 (PSGL-1) homozygous knockout (PSGL-1
/)
mice on the C57/BL6J background (19,20) were purchased as 6-week-old
animals from The Jackson Laboratory (Bar Harbor, ME). All mice used in this
study were males and were maintained under a 12-h light/12-h dark cycle with
access to food and tap water ad libitum. The animal care and all procedures
were done according to the Guidelines for Animal Experimentation at
Okayama University Medical School, the Japanese Government Animal Pro-
tection and Management Law (number 105), and the Japanese Government
Notiﬁcation on Feeding and Safekeeping of Animals (number 6).
Experimental protocol
Protocol 1. The db/db mice and the WT (C57/BL6) mice were fed a normal
diet (Oriental Yeast, Osaka, Japan). All mice were killed at 8 weeks old, and
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diabetes.diabetesjournals.org DIABETES, VOL. 60, JANUARY 2011 189epididymal white adipose tissue (eWAT) was harvested, weighed, and ﬁxed in
10% (vol/vol) formalin. The remaining tissue was stored at 80°C.
Protocol 2. BL6 mice were fed HFD consisting of 60% kcal fat or a low-fat diet
(LFD) consisting of 10% kcal fat (D12492 and D12450B, respectively; Research
Diets, New Brunswick, NJ) from 7 to 19 weeks old. Intraperitoneal glucose
and insulin tolerance tests were done at 15 or 16 weeks old. All mice were
killed at 19 weeks old.
Protocol 3. PSGL-1
/ and PSGL-1
/ (WT; C57/BL6) mice were fed HFD
from 7 to 17 weeks old. Intraperitoneal glucose and insulin tolerance tests
were done at 15 or 16 weeks old. All mice with 40 g body weight were killed
at 17 weeks old. PSGL-1
/ mice were healthy and showed delayed neutrophil
recruitment and moderate neutrophilia.
Analysis of metabolic parameters. Body weight and food intake were
monitored weekly. For the glucose tolerance test, the mice were injected with
glucose (1.2 g/kg body mass i.p.) after fasting for 12–16 h. For the insulin
tolerance test, mice allowed access to food ad libitum were injected with
human regular insulin (0.7 units/kg body mass i.p., Eli Lilly, Indianapolis, IN).
We measured the concentration of glucose with a blood glucose meter
(Glutest Pro; Sanwa Kagaku Kenkyusho, Nagoya, Japan), plasma insulin and
leptin with an assay kit (Morinaga Institute of Biological Science, Kanagawa,
Japan), and plasma adiponectin with an ELISA kit (Otsuka Pharmaceutical,
Tokyo, Japan).
RNA preparation from eWAT and liver. Total RNA was extracted from
each specimen of eWAT and liver using the RNeasy Lipid Tissue Mini Kit or
RNeasy Plus Mini Kit following the instructions provided by the manufacturer
(Qiagen, Valencia, CA).
DNA microarray analysis. We used ﬁve RNA samples from each group
(db/db versus WT mice and BL6 mice fed HFD versus LFD) for DNA
microarray analysis. Preparation of cRNA and hybridization of probe arrays
(Mouse Genome 430 2.0) were performed according to the manufacturer’s
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FIG. 1. A: Metabolic characteristics of db/db and WT mice. Metabolic parameters of 8-week-old WT mice () and db/db mice (f) are shown. B:
Gene expression in epididymal fat from 8-week-old WT mice () and db/db mice (f) analyzed by quantitative real-time RT-PCR. Data are
means  SE. *P < 0.05, **P < 0.005 vs. WT. n  10 for each group.
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45,000 transcripts. The criteria for selecting genes were as follows: 1) genes
whose ﬂags were “present” and 2) ratio of expression level of 2.0-fold
increase in db/db compared with WT mice or in BL6 mice fed HFD compared
with LFD. Gene Ontology Biological Process classiﬁcation of the 2.0-fold
upregulated genes from each group was done with the DAVID Bioinformatics
Database functional-annotation tools (http://niaid.abcc.ncifcrf.gov) (21).
Quantitative real-time RT-PCR analysis for eWAT and liver. The mRNA
expression of each gene was measured by quantitative real-time RT-PCR as
described previously (22). The amounts of PCR products were normalized
with a housekeeping gene (-actin or GAPDH) to calculate the relative
expression ratios. Each experiment was done in triplicate. The primers were
as follows: MCP-1: 5-AAGCTGTAGTTTTTGTCACC-3 (forward), 5-GGGCA
GATGCAGTTTTAA-3 (reverse); PSGL-1 (Selpl): 5-TTGTGCTGCTGAC
CATCT-3 (forward), 5-TCCTCAAAATCGTCATCC-3 (reverse); P-selectin
(Selp): 5-CAGTGGCTTCTACAACAGGC-3 (forward), 5-T GGGTCATATG
CAGCGTTA-3 (reverse); E-selectin (Sele): 5-CATGGCTCAGCTCAACTT-3
(forward), 5-GCAGCTCATGTTCATCTT-3 (reverse); CD68: 5-GCGGTG
GAATACAATGTG-3 (forward), 5-AGAGAGAGCAGGTCAAGGT-3 (reverse);
-actin: 5-CCTGTATGCCTCTGGTCGTA-3 (forward), 5-CCATCTCCTGCTC
GAAGTCT-3 (reverse).
These primers were purchased from Nihon Gene Research Labs (Sendai,
Japan). ICAM-1 (GenBank accession code X52264, cat. no. 4651782) and NOS2
(iNOS) (GenBank accession code NM_010927, cat. no. 5026474) were in
the Light Cycler-Primer Set (Roche Diagnostics, Rotkreuz, Switzerland). F4/80
(Mm01236959_m1), CD11c (Mm00498698_m1), IL-10 (Mm01288386_m1), IL-6
(Mm0046190_m1), LPL (Mm00434770_m1), leptin (Mm00434759_m1), fatty
acid synthase (FAS) (Mm00662319_m1), sterol regulatory element binding
protein-1c (SREBP-1c) (Mm0113844_m1), acetyl-CoA carboxylase-1 (ACC-1)
(Mm01304289_m1), and peroxisome proliferator–activated receptor-
(PPAR-) (Mm00627559_m1) were TaqMan gene expression assays (Applied
Biosystems, Tokyo, Japan).
Isolation of adipocytes and stromal-vascular fractions. Stromal vascular
fraction (SVF) cells and peripheral blood mononuclear cells (PBMCs) were
isolated from db/db mice or BL6 mice at 10 weeks of age. SVF cells were
isolated as described (23,24). PBMCs were separated by density gradient
centrifugation using a Lymphocyte Separation Medium (MP Biomedicals,
Solon, OH). Cells in the SVF and PBMCs were analyzed by ﬂow cytometry.
Flow cytometry analysis. SVF cells or PBMCs were suspended in Pharmin-
gen stain buffer (BD Biosciences, San Jose, CA) and incubated for 10 min with
Fc-block and then with primary antibodies or the matching control isotypes
for 30 min at 4°C. Then, the pellets were incubated with RBC Lysis Buffer
(eBioscience, San Diego, CA) for 5 min and rinsed twice with Pharmingen
stain buffer. After incubation with 7-amino-actinomycin D (BD Biosciences),
the cells were analyzed using a FACS Calibur (BD Biosciences). Data analysis
was performed using CELL Quest (BD Biosciences).
In vivo Akt phosphorylation. WT mice and PSGL-1
/ mice fed HFD were
starved for 14 h, anesthetized with pentobarbital, and injected with 5 units of
regular human insulin into the inferior vena cava. Five minutes later, the
livers, eWAT, and hindlimb muscle were excised and stored at 80°C until
use. Tissue samples were homogenized in RIPA Lysis buffer (Santa Cruz
Biotechnology, Santa Cruz, CA) at 4°C. After centrifugation at 13,000 rpm for
30 min at 4°C, supernatant was collected. Total protein concentration was
determined by using the DC-protein determination system (Bio-Rad Labora-
tories) and an equivalent amount of protein (40–60 g). Samples were
resolved by SDS-PAGE and transferred to a nitrocellulose membrane with
iBlot Dry Blotting System (Invitrogen). The membranes were blocked with 5%
nonfat dry milk in 1	 Tris-buffered saline containing 0.1% Tween-20 for 1 h
and incubated overnight with anti–phospho-Akt (Ser473) antibody and anti-
Akt antibody (Cell Signaling Technology, Danvers, MA) at 4°C. After incuba-
tion with horseradish peroxidase–labeled secondary antibodies for 1 h, signals
were detected with an enhanced chemiluminescence system (Amersham).
Membranes were exposed in an Image system LAS-3000 (FujiFilm) and
analyzed by using Image J software.
Light microscopy and morphometric analysis of adipocyte area. eWAT
was isolated from mice, ﬁxed in 10% formalin, and embedded in parafﬁn.
Parafﬁn sections (4 m thick) were deparafﬁnized and rehydrated and then
stained with periodical acid Schiff stain. The adipocyte area was traced
manually and analyzed with Lumina Vision OL V2.4.4 software (Mitani, Tokyo,
Japan). The area was measured in six high-power ﬁelds from each of ﬁve mice.
Immunohistochemical staining. Immunoperoxidase and immunoﬂuorescent
staining were done as described (11,12,25). Parafﬁn sections were deparafﬁnized
and rehydrated before antigen unmasking by boiling in R-Buffer U at a dilution of
1:10 (PickCell Laboratories, Amsterdam, the Netherlands) for 10 min.
We used immunoperoxidase staining for macrophage and PSGL-1 in eWAT
of db/db mice and WT mice on normal food. Rat anti-mouse monocyte/
macrophage (Mac-3) monoclonal antibody (mAb) at a dilution of 1:50 (Santa
Cruz Biotechnology) and rat anti-mouse PSGL-1 (CD162) mAb at a dilution of
1:50 (Fitzgerald Industries International, Concord, MA) were applied to the
sections as the primary reaction, followed by a second reaction with biotin-
labeled donkey anti-rat IgG antibody (Jackson Immunoresearch Laboratories,
West Grove, PA) at a dilution of 1:50. The avidin-biotin coupling reaction was
done with the Vectastain Elite kit (Vector Laboratories, Burlingame, CA).
We used double immunoﬂuorescence staining to clarify the expression and
localization of PSGL-1, leukocyte/macrophage, and endothelial cells in eWAT
of db/db mice. PSGL-1 mAb followed by Alexa Fluor 488 donkey anti-rat IgG
(A-21208; Molecular Probes, Eugene, OR) and goat anti-mouse leukocyte/
macrophage (CD45) mAb (sc-1121; Santa Cruz Biotechnology) followed by
TABLE 1
DNA microarray analysis
Fibulin 2 Selectin, lymphocyte
CD97 antigen Integrin alpha x
Parvin, gamma C-type lectin domain family 7, member a
C-type lectin domain family 4, member e Metastasis suppressor 1
A disintegrin and metallopeptidase domain 8 Procollagen, type iii, alpha 1
Integrin alpha m Scavenger receptor class b, member 2
Killer cell lectin-like receptor, subfamily a, member 2 Protein tyrosine phosphatase, non-receptor type substrate 1
Procollagen, type I, alpha 1 Proline-serine-threonine phosphatase-interacting protein 1
Selectin, platelet (p-selectin) ligand Colony-stimulating factor 3 receptor (granulocyte)
Integrin alpha 7 CD36 antigen
Expressed sequence c79673 Ninjurin 1
Procollagen, type v, alpha 3 Vav 1 oncogene
Plakophilin 2 Glycoprotein (transmembrane) nmb
Elastin microﬁbril interfacer 2 CD22 antigen
Cell adhesion molecule with homology to l1cam Riken cdna c030017f07 gene
Integrin beta 2 Secreted phosphoprotein 1
Milk fat globule-EGF factor 8 protein Protocadherin 19
Pleckstrin homology, sec7 and coiled-coil domains, binding protein Procollagen, type viii, alpha 1
CD44 antigen Integrin beta 1 binding protein 1
Calsyntenin 2 Parvin, beta
Carboxypeptidase x 1 (m14 family) Leupaxin
A disintegrin and metallopeptidase domain 23 Neuropilin 2
Oxidized low density lipoprotein (lectin-like) receptor 1 Complement component 1, q subcomponent, receptor 1
Procollagen, type v, alpha 2
Gene ontology of cell adhesion category of more than twice upregulated genes db/db versus wild-type mice is shown (total, 47 genes).
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to the sections. Similarly, PSGL-1 mAb followed by Alexa Fluor 488 donkey
anti-rat IgG and goat anti-mouse endothelial cell (PECAM-1/CD31) mAb
(sc-1506; Santa Cruz Biotechnology) followed by Alexa Fluor 546 rabbit
anti-goat IgG were applied to the sections.
Measurement of hepatic triglyceride content. Measurement of the hepatic
triglyceride content in WT mice and PSGL-1
/ mice fed HFD was done by the
Folch technique (26) at Skylight Biotech (Akita, Japan), and the triglyceride
concentration was measured with Cholestest TG (Sekisui Medical, Tokyo,
Japan). The tissue triglyceride concentrations were corrected for liver weight.
Statistical analysis. All data are expressed as mean 
 SE and were analyzed
by the Mann-Whitney U test with the level of statistical signiﬁcance set at P 
0.05.
RESULTS
Analysis of eWAT from db/db mice. The db/db mice
showed signiﬁcantly increased body weight, weight of
eWAT, levels of serum LDL cholesterol, postprandial
plasma glucose, and plasma insulin compared with WT
mice, but A1C was not different between the two groups
(Fig. 1A).
DNA microarray analysis detected 1,080 genes that
were more than twofold upregulated in db/db mice
compared with WT mice. Gene ontology analysis indi-
cated that 47 cell adhesion-related genes, including
L-selectin (2.0-fold change, db/db versus wild-type) and
PSGL-1 (2.0-fold change, db/db versus wild-type) were up-
regulated in db/db mice compared with WT mice (supple-
mentary Fig. 1, available in an online-only appendix at
http://diabetes.diabetesjournals.org/cgi/content/full/db09-
1894/DC1; Table 1).
We focused on PSGL-1 because it is expressed on both
PSGL-1 MAC-3 
wild type
db/db
db/db
A
PSGL-1 CD45 merge
PSGL-1 CD31 merge
B
C
D
E
F
FIG. 2. A: Immunohistochemical localization of PSGL-1, macrophages, and endothelial cells in adipose tissue. Epididymal fat pads from 8-week-old
db/db mice and WT mice were stained with anti–MAC-3 (left-hand panels) and anti–PSGL-1 antibodies (right-hand panels). Macrophages and
PSGL-1 expressed around the small vessels in the interstitium of adipose tissue in db/db mice are shown. The scale bars represent 50 m. B:
Double immunoﬂuorescence staining of adipose tissue from db/db mice with the antibodies against PSGL-1 (green) and leukocyte (CD45, red).
PSGL-1 and CD45 were stained in the interstitium of adipose tissue and are colocalized in the merged picture. C: Double immunoﬂuorescence
staining of adipose tissue from db/db mice with the antibodies against PSGL-1 (green) and endothelial cell (CD31, red). PSGL-1 and CD31 were
stained along small vessels of adipose tissue and are colocalized in the merged picture. D–F: The expression of PSGL-1 on cells in WT mice and
db/db mice was analyzed using ﬂow cytometry. D: The expression of PSGL-1 in PBMCs. E: The expression of PSGL-1 in F4/80
 macrophages in
the SVF from adipose tissue. F: The expression of PSGL-1 in CD31
 endothelial cells in the SVF from adipose tissue. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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binding capacity to all three types of selectin (27–29).
Real-time RT-PCR demonstrated that PSGL-1 mRNA ex-
pression was signiﬁcantly higher in eWAT of db/db mice
compared with that in WT mice. The transcriptional levels
of other proinﬂammatory genes, including F4/80, MCP-1,
and P-selectin mRNA, were also increased signiﬁcantly in
db/db mice (Fig. 1B), whereas the mRNA expression of
other adhesion molecule genes, such as E-selectin and
ICAM-1, in db/db mice was not different from that in WT
mice.
Immunoperoxidase staining was used for MAC-3, a
macrophage marker, and PSGL-1 in eWAT from db/db
mice and WT mice fed normal diet. The expression of
macrophage and PSGL-1 increased around the small ves-
sels in the interstitium of eWAT in db/db mice (Fig. 2A).
Furthermore, to estimate the distribution of PSGL-1, mac-
rophage, and endothelial cells in eWAT, we used double
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FIG. 3. A: Metabolic characteristics of C57/BL6
mice fed LFD or HFD from 7 to 19 weeks old.
Metabolic parameters of mice fed LFD diet (E,
) or HFD (F, f) are shown (n  9 [LF]; n  11
[HF]). B: Blood glucose level (left-hand panel)
and plasma insulin levels (right-hand panel)
during the glucose tolerance test (1.2 g/kg body
mass) (n  9 [LF], E; n  11 [HF], F). C: Blood
glucose level during the insulin tolerance test
(0.7 units/kg body mass) (n  9 [LF], E; n  11
[HF], F). D: Gene expression in epididymal fat
from C57/BL6 mice fed a LFD () or HFD (f)
from 7 to 19 weeks old analyzed by quantitative
real-time RT-PCR (n  9 [LF], n  10 [HF]).
Data are means  SE. *P < 0.05 vs. LFD, **P <
0.005 vs. LFD.
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PSGL-1 (green) and leukocyte/macrophage (CD45, red)
were detected in the interstitium of eWAT. They were
mostly coexpressed in a merged picture (Fig. 2B). In
addition, PSGL-1 (green) and endothelial cells (CD31, red)
were mostly detected in the interstitium of eWAT and
mostly coexpressed in a merged picture (Fig. 2C).
We examined PBMCs from WT mice or db/db mice.
F4/80
PSGL-1
 cells were similarly contained (WT mice
82.3 
 1.2% versus db/db mice 84.6 
 2.5% of F4/80
 cells,
P  0.827) between the two groups by ﬂow cytometry
analysis. We isolated SVF cells from epididymal fat pads
excised from WT mice or db/db mice fed a normal diet and
analyzed cells by ﬂow cytometry. F4/80
PSGL-1
 cells
were not different (WT mice 23.2 
 2.2% versus db/db mice
34.3 
 4.3% of F4/80
 cells, P  0.149) between WT mice
and db/db mice. CD31
PSGL-1
 cells signiﬁcantly in-
creased (WT mice 36.6 
 2.5% versus db/db mice 53.9 

3.5% of CD31
 cells, P  0.021) in db/db mice compared
with WT mice (Fig. 2D–F). These results indicate that
CD31
PSGL-1
 cells were increased in adipose tissue of
db/db mice.
Upregulation of PSGL-1 expression in BL6 mice fed
HFD. We next examined eWAT in BL6 mice fed LFD or
HFD to determine whether PSGL-1 expression increased
in HFD-induced obese mice. BL6 mice fed HFD showed
signiﬁcantly increased body weight, weight of eWAT,
serum LDL cholesterol, fasting plasma glucose, plasma
insulin, and A1C compared with BL6 mice fed LFD (Fig.
3A). Plasma glucose and insulin levels during a glucose
tolerance test were markedly higher in BL6 mice fed HFD
compared with mice fed LFD (Fig. 3B). Similarly, BL6
mice fed HFD showed impaired insulin sensitivity as
measured by the insulin tolerance test (Fig. 3C).
DNA microarray proﬁling indicated that 572 genes were
upregulated more than twofold in BL6 mice fed HFD
compared with those fed LFD. Analysis by gene ontology
categories showed that 41 cell adhesion–related genes,
including PSGL-1, were upregulated in BL6 mice fed HFD
(twofold change, HFD/LFD) (supplementary Fig. 2, Table
2). Quantitative real-time RT-PCR showed that transcrip-
tional levels of CD68, MCP-1, PSGL-1, and P-selectin
mRNA were increased signiﬁcantly in BL6 mice fed HFD.
E-selectin and ICAM-1 mRNA expression were not differ-
ent between the two groups (Fig. 3D).
PSGL-1 deﬁciency improved insulin sensitivity. As
described above, PSGL-1 was upregulated in eWAT of two
different rodent models for obesity-related insulin resis-
tance. We further examined the role of PSGL-1 in eWAT of
diet-induced obese mice using PSGL-1–deﬁcient (PSGL-
1
/) mice. The PSGL-1
/ and PSGL-1
/ WT mice were
fed HFD for 10 weeks.
Body weight, the weight of each adipose tissue per unit
body weight, and food intake were not different between
the two groups (Fig. 4A). There was no difference in
fasting plasma glucose and A1C between the two groups,
although fasting plasma insulin level was signiﬁcantly
lower in PSGL-1
/ mice than it was in WT mice fed HFD
(Fig. 4B). These data indicated that PSGL-1 deﬁciency
improved insulin resistance without a change of body
weight or the amount of eWAT.
Intraperitoneal glucose and insulin tolerance tests
were used to further conﬁrm that PSGL-1 deﬁciency
improves insulin sensitivity. Blood glucose levels during
the glucose tolerance test were similar in the two
groups, although plasma insulin levels were lower in
PSGL-1
/ mice than those in WT mice fed HFD (Fig.
4C). The glucose-lowering effect of insulin was signiﬁ-
cantly greater in PSGL-1
/ mice than it was in WT
mice, as measured by the insulin tolerance test (Fig.
4D). These data conﬁrmed that insulin sensitivity was
improved in PSGL-1
/ mice fed HFD.
To further investigate insulin sensitivity in PSGL-1
/
mice, we examined insulin-stimulated phosphorylation of
Akt in liver and muscle. Akt phosphorylation in liver was
not different between the two groups. However, Akt
phosphorylation in muscle was signiﬁcantly increased
in PSGL-1
/ mice compared with WT mice fed HFD
(Fig. 4E).
TABLE 2
DNA microarray analysis
Connective tissue growth factor CD44 antigen
TNF receptor superfamily, member 12a Procollagen, type vi, alpha 3
Thrombospondin 1 Carboxypeptidase x 1 (m14 family)
Cysteine rich protein 61 Cartilage acidic protein 1
rho GTPase activating protein 6 Integrin alpha x
Procollagen, type VI, alpha 2 C-type lectin domain family 7, member a
Riken cdna 2700007f12 gene Vav 3 oncogene
A disintegrin and metallopeptidase domain 8 Neural precursor cell expressed, developmentally
downregulated gene 9
CD9 antigen Discoidin, cub and lccl domain containing 2
Poliovirus receptor Procollagen, type vi, alpha 1
Filamin binding lim protein 1 Periostin, osteoblast speciﬁc factor
A disintegrin and metallopeptidase domain 12 (meltrin alpha) Protein tyrosine phosphatase, non-receptor type substrate 1
Calsyntenin 3 Proline-serine-threonine phosphatase-interacting protein 1
Poliovirus receptor-related 3 Tenascin c
Integrin alpha m Vav 1 oncogene
Selectin, platelet (p-selectin) ligand Glycoprotein (transmembrane) nmb
Procollagen, type I, alpha 1 Activated leukocyte cell adhesion molecule
Expressed sequence c79673 Secreted phosphoprotein 1
Immunoglobulin superfamily, member 4a Procollagen, type viii, alpha 1
Integrin beta 2 Leupaxin
Pleckstrin homology, sec7 and coiled-coil domains, binding protein
Gene ontology of cell adhesion category of more than twice upregulated genes HFD versus LFD is shown (total, 41 genes).
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FIG. 4. A: Metabolic characteristics of WT mice and PSGL-1
/ (KO) mice fed HFD from 7 to 17 weeks old. Body composition and food intake in
WT mice () and PSGL-1
/ mice (f) fed HFD (n  7 [WT-HF]; n  8 [KO-HF]) is shown. B: Metabolic parameters of WT mice () and PSGL-1
/
mice (f) fed HFD (n  7 [WT-HF]; n  8 [KO-HF]). C: Blood glucose level (upper panel) and plasma insulin levels (lower panel) during the
glucose tolerance test (1.2 g/kg body mass) (n  9 [WT-HF], E; n  8 [KO-HF], F). D: Blood glucose level during the insulin tolerance test (0.7
units/kg body mass) (n  9 [WT-HF], E; n  8 [KO-HF], F). Data are means  SE. *P < 0.05 vs. WT-HFD, **P < 0.005 vs. WT-HFD. E: Equal
amounts of protein in total lysates of liver and muscle were immunoblotted with anti–phospho-Akt (pAkt) and anti-Akt antibodies. The relative
ratio of Akt phosphorylation was calculated after normalization with the Akt signal (n  5 [WT-HF], ; n  5 [KO-HF], f). Data are means  SE.
*P < 0.05 vs. WT-HFD. FFA, free fatty acid.
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and inﬂammation in obese adipose tissue. Morphomet-
ric analysis demonstrated that adipocytes in eWAT were
smaller in PSGL-1
/ mice than in WT mice fed HFD (Fig.
5A and B). Immunohistochemistry showed a decrease of
MAC-3–positive cells in eWAT from PSGL-1
/mice fed HFD
(Fig. 5C). The mRNA expression of F4/80, MCP-1, IL-6, iNOS,
and leptin was decreased in eWAT from PSGL-1
/ mice
compared with that in WT mice fed HFD (Fig. 5D), although
the levels of TNF- and adiponectin mRNA were not
statistically different between the two groups (data not
shown). IL-10 mRNA levels were signiﬁcantly increased,
whereas CD11c mRNA levels tended to be decreased
without signiﬁcant difference in PSGL-1
/ mice fed
HFD compared with WT mice fed HFD (Fig. 5D).
PSGL-1 deﬁciency improved lipid metabolism and
hepatic steatosis. In this study, the weight of liver and
the level of serum triglycerides were reduced signiﬁcantly,
and the hepatic triglyceride content tended to be de-
creased in PSGL-1
/ mice compared with WT mice fed
HFD (Figs. 4B and 6A). The mRNA expression of CD68
was not different between the two groups. (Fig. 6B). A few
lipid metabolism–related genes in liver were not different
between the two groups as follows: FAS (WT-HF 9.37 

3.07 vs. KO-HF 5.37 
 1.38, P  0.223), SREBP-1c (WT-HF
3.29 
 0.48 vs. KO-HF 3.77 
 0.64, P  0.685), ACC-1
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FIG. 5. A: Periodical acid Schiff staining of epididymal fat sec-
tions from WT mice (left-hand panel) and PSGL-1
/ (KO) mice
(right-hand panel) fed HFD for 10 weeks. The scale bars repre-
sent 100 m. B: Distribution of adipocyte size in epididymal fat
tissues from WT mice () and PSGL-1
/ mice (f). Data are the
mean from analysis of six high-power ﬁelds from each of ﬁve
mice. C: Immunohistochemical detection of Mac-3 in epididymal
fat tissue from WT mice (upper panels) and PSGL-1
/ mice
(lower panels) fed HFD. Macrophage inﬁltration into epididymal
fat tissue decreased in PSGL-1
/ mice. Scale bars, 50 m. D:
Gene expression of F4/80, CD11c, IL-10, MCP-1, IL-6, iNOS,
leptin, and LPL in epididymal fat tissues from WT mice () and
PSGL-1
/ mice (f) fed HFD analyzed by quantitative real-time
RT-PCR (n  7 [WT-HF]; n  7 [KO-HF]). Data are means  SE.
*P < 0.05, **P < 0.01, ***P < 0.0001 vs. WT-HFD. (A high-quality
digital representation of this ﬁgure is available in the online
issue.)
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 2.63 vs. KO-HF 19.59 
 3.09, P  0.935),
PPAR- (WT-HF 24.45 
 5.25 vs. KO-HF 22.93 
 4.03, P 
0.685), and LPL (WT-HF 1.17 
 0.15 vs. KO-HF 1.95 
 0.79,
P  0.685). (The amounts of PCR products were normal-
ized with a housekeeping gene [GAPDH] to calculate the
relative expression ratios.) On the other hand, the mRNA
expression of LPL in adipose tissue improved in PSGL-
1
/ mice compared with WT mice fed HFD (Fig. 5D).
Histologically, the liver of WT mice fed HFD showed
massive hepatocyte ballooning around the central veins;
however, the hepatic steatosis was improved in PSGL-1
/
mice fed HFD (Fig. 6C). Furthermore, the levels of serum
total cholesterol, LDL, free fatty acids, and leptin were
lower in PSGL-1
/ mice than in WT mice fed HFD (Fig.
4B), but aspartate aminotransferase and alanine amino-
transferase were not different between the two groups
(data not shown).
DISCUSSION
To investigate the mechanism of monocytes/macrophages
inﬁltration into adipose tissue, we used a DNA microarray
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FIG. 6. A: Liver weight (left) and hepatic triglyceride (right) in WT mice () and PSGL-1
/ (KO) mice (f) fed HFD for 10 weeks (n  5 [WT-HF];
n  8 [KO-HF]). Data are means  SE. *P < 0.05 vs. WT-HFD. B: Gene expression of CD68 in liver from WT mice () and PSGL-1
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fed HFD diet analyzed by quantitative real-time RT-PCR (n  5 [WT-HF]; n  8 [KO-HF]). Data are means  SE. C: Hematoxylin and eosin stain.
Hepatic steatosis is prominent in the liver of WT mice fed HFD. The scale bars represent 100 m. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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HFD. Both groups were in a state of intensive insulin
resistance but were not diabetic. Expression of the adhe-
sion molecule PSGL-1 was increased in obese adipose
tissue from db/db mice and from WT mice fed HFD, as
determined by DNA microarray analysis. In addition, an
increase in PSGL-1 mRNA expression was observed with
real-time RT-PCR and immunohistochemistry in obese
adipose tissue. Furthermore, PSGL-1–deﬁcient mice had
reduced macrophage accumulation, insulin resistance,
lipid metabolism, and steatohepatic change associated
with obesity.
PSGL-1 was originally identiﬁed by expression cloning
of a functional ligand for P-selectin (30). PSGL-1 is a
mucin-like cell adhesion molecule expressed on the sur-
face of leukocytes and endothelial cells and then involved
in platelet-leukocyte and endothelium-leukocyte interac-
tions. PSGL-1 mRNA was expressed in a variety of tissues,
including bone marrow, brain, adipose tissue, heart, kid-
ney, and liver. PSGL-1 is highly expressed in hematopoi-
etic cells and in nonhematopoietic tissues, including
adipose tissue and brain. The domain structure of PSGL-1
and amino acids are highly conserved between humans
and rodents (31). PSGL-1 interacts with all three selectins:
L-selectin (32), E-selectin (19,22), and P-selectin (29).
Earlier, it was reported that mice deﬁcient in ICAM-1, or
other leukocyte adhesion molecules, increased body
weight and white fat pad weight (% of body weight) on
normal food and on HFD. Mac-1 (M2, CD11b/CD18) is a
counter-receptor for ICAM-1, and Mac-1–deﬁcient mice
showed a similar obesity phenotype (33). A1C was not
different in ICAM-1–deﬁcient db/db mice, streptozotocin-
induced ICAM-1–deﬁcient mice, db/db mice (13), and
streptozotocin-induced WT mice (12). Furthermore, the
number of leukocytes in the adipose tissue of ICAM-1–
deﬁcient mice and Mac-1–deﬁcient mice fed HFD were the
same as in the WT mice fed HFD. Consequently, these
adhesion receptors are not required for leukocyte migra-
tion into adipose tissue (34).
In this study, PSGL-1 expression on peripheral blood
monocyte was not increased in db/db mice compared with
WT mice. Moreover, PSGL-1 expression on ATMs was also
similar between db/db mice and WT mice by ﬂow cytom-
etry analysis. On the other hand, CD31
PSGL-1
 cell
content was signiﬁcantly increased in the SVF of eWAT in
db/db mice compared with WT mice. These results indi-
cate that increased expression of PSGL-1 on endothelial
cells in adipose tissue is involved in inﬁltration of macro-
phage and inﬂammation in adipose tissue of obese mice.
The accumulation of macrophages in adipose tissue is
correlated with increased body weight and insulin resis-
tance in both humans and rodents (2,3). MCP-1 contrib-
uted to macrophage inﬁltration into adipose tissue and
insulin resistance in mice (6,8). Those reports indicated
that the ATMs might play an important role in the devel-
opment of insulin resistance. Moreover, there are recent
reports that the polarization of macrophages is changed
from M2 to M1 in obese inﬂamed adipose tissue (35). M1
macrophages are induced by proinﬂammatory mediators
such as lipopolysaccharide and -interferon (IFN-) and
produce proinﬂammatory cytokines TNF- and IL-6. In-
stead, M2 macrophages generate high levels of anti-inﬂam-
matory cytokines IL-10 and IL-1. Our data showed that
MCP-1, IL-6, and iNOS mRNA levels were reduced, and
IL-10 mRNA, an M2 macrophage marker, was signiﬁcantly
increased in eWAT from PSGL-1
/ mice compared with
WT mice fed HFD. Whereas CD11c mRNA as an M1
macrophage marker tended to be decreased in PSGL-1
/
mice compared with WT mice fed HFD. These results
demonstrated that PSGL-1 deﬁciency reduced the number
of ATMs and changed the phenotype of macrophages from
M1 to M2 and then affected inhibition of inﬂammation in
eWAT. Furthermore, PSGL-1 deﬁciency improved insulin
signaling in the muscle, as evidenced by an increase in Akt
phosphorylation in animals fed HFD. As a result, PSGL-
1
/ mice fed HFD ameliorated systemic glucose toler-
ance and insulin sensitivity.
Several studies reported that blockade of PSGL-1 reduced
inﬂammatory reactions. In the model of cold ischemia/
reperfusion, hepatic endothelial neutrophil inﬁltration and
hepatocyte injury were diminished, and the expression of
TNF-, IL-6, iNOS, IL-2, and IFN- mRNA was decreased in
livers pretreated with recombinant PSGL-Ig (36). Other re-
ports showed that blockade of PSGL-1 attenuated macro-
phage recruitment in intestinal mucosa and ameliorated
ileitis in a mouse model of Crohn’s disease (37,38).
In this study, serum triglyceride and hepatic steatosis
improved in PSGL-1
/ mice fed HFD. The mRNA expres-
sion of LPL was improved in adipose tissue of PSGL-1
/
mice compared with WT mice fed HFD. These results
might be explained if the amelioration of insulin resistance
increased LPL in adipose tissue. Consequently, lipid me-
tabolism, including serum free fatty acids, triglyceride,
cholesterol, and hepatic triglycerides, might be improved
in PSGL-1
/ mice compared with WT mice fed HFD.
We found that plasma leptin levels and leptin mRNA
expression in eWAT were decreased in PSGL-1
/ mice
fed HFD, despite no difference of body weight or weight of
fat. The plasma leptin concentration is positively corre-
lated with BMI and weight of body fat in humans (39).
Obese individuals are generally in a state of leptin resis-
tance, although the pathophysiology of leptin resistance
has not been clariﬁed. Our data suggested that improve-
ment of leptin sensitivity resulted in lower levels of plasma
leptin in PSGL-1
/ mice than that in WT mice fed HFD.
However, further studies are needed to determine whether
PSGL-1 deﬁciency improves leptin sensitivity in obese
animals.
In conclusion, our results indicate that PSGL-1 is a
crucial adhesion molecule for recruitment of monocytes
into adipose tissues in obese mice. PSGL-1 is a candidate
for a novel therapeutic target for prevention of obesity-
related insulin resistance.
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